This week I cover another of my meta-research projects, this one on systematic review and meta analysis (SRMA) growth as compared to randomized clinical trial (RCT) growth.  Short and to the point - hope you enjoy! I highly recommend checking out the associated graphs - just take a quick peek at some point while listening. Find them on my twitter handle @ebrheum 

Active comparator trial! Always my favorite.  Lots of fun topics in this one, including noninferiority trials, crafty endpoints, and PROs.  Check it out and let me know what you think! @ebrheum 

Another day, another lupus trial, another round of endpoint shenanigans.  Why does that matter? How big is the benefit from belimumab in SLE nephritis? Will this save lives and prevent ESRD / RRT? I try to tackle these issues this week and (hopefully) avoid getting myself in trouble.  Hope you enjoy the episode!  Let me know what you think @ebrheum on twitter!